Vaccines against Aujeszy's disease
Toma, B.
Developments in Biological Standardization 52: 407-413
1982
ISSN/ISBN: 0301-5149 PMID: 6299851 Document Number: 188046
Document emailed within 1 workday
Related Documents
Petricciani, J. 2004: Are cancer vaccines really the same as infectious disease vaccines? Developments in Biologicals 116: 13-18Mangtani, P.; Mulholland, K.; Madhi, S.A.; Edmond, K.; O'Loughlin, R.; Hajjeh, R. 2010: Haemophilus influenzae type b disease in HIV-infected children: a review of the disease epidemiology and effectiveness of Hib conjugate vaccines Vaccine 28(7): 1677-1683
Strom, M.S.; Rhodes, L.D.; Corbett, S.C.; Rathbone, C.K.; Harrell, L.W. 2002: Task 10. Use of antibiotics and new vaccines to reduce mortality from bacterial kidney disease in chinook salmon (final report: 1 June 2000 through 31 May 2001) (final report: 1 June 2001 through 31 May 2002) - (Experiment A. Study the efficacy of other vaccines) BPA Report DOE/BP 000(05227-2): 74-90
Nöckler, A.; Thalmann, G.; Haack, P.; Nehmzow, P.; Poewe, R.; Pietzsch, E.; Seils, G. 1990: Riems foot-and-mouth disease oil emulsion vaccines for swine. 2. use of foot-and-mouth 2-component oil emulsion vaccines in practice Archiv für Experimentelle Veterinarmedizin 44(2): 183-188
Ochoa-Grullon, J.; Morado, C.; Macarron, P.; Freites, D.; Diaz, I.; Nuñez-Beltrán, M.; Rodriguez de la Peña, A.; Comins-Boo, A.; Llano Hernández, K.; Rodriguez, E.; Toledano, E.; Fernandez, B.; Sanchez-Ramόn, S.; Candelas, G. 2016: AB1007Recurrent Infection after Biologicals in Autoimmune Disease: Preliminary Results with Mucosal Vaccines Recurrent Infection after Biologicals in Autoimmune Disease: Preliminary Results with Mucosal Vaccines Annals of the Rheumatic Diseases 75(Suppl 2): 1246.1-1246
Bengelsdorff, H.J.; Keller, A.L.; Bernhardt, D. 1973: Efficiency studies on vaccines against Marek's disease, based on turkey herpes virus against the Marek disease Deutsche Tierärztliche Wochenschrift 80(18): 417-420
Banker, D.D. 1998: New vaccines for disease prevention Indian Journal of Medical Sciences 52(3): 125-129
Nau, J.-Y. 2005: Vaccines for Alzheimer's disease? Revue Medicale Suisse 1(27): 1819
Ingwersen, P.; Kraft, V.; Monreal, G. 1974: Stability of vaccines against Marek's disease Deutsche Tierärztliche Wochenschrift 81(13): 302-304
Keith, J.A.; Agostini Bigger, L.; Arthur, P.A.; Maes, E.; Daems, R. 2013: Delivering the promise of the Decade of Vaccines: opportunities and challenges in the development of high quality new vaccines Vaccine 31(Suppl 2): B184-B193
Wegmann, A.; Glück, R.; Just, M.; Mischler, R.; Paroz, P.; Germanier, R. 1986: Comparative study and evaluation of further attenuated, live measles vaccines alone and in combination with mumps and rubella vaccines Developments in Biological Standardization 65: 69-74
Prince, A.M.; Vnek, J. 1982: Hepatitis B vaccines. An evaluation of human plasma extracted vaccines Fortschritte der Medizin 100(40): 1839-1843
Crosnier 1962: Anti-poliomyelitis vaccinations. Live vaccines and inactivated vaccines. Respective indications. Current status of the problem Revue de Pathologie Generale et de Physiologie Clinique 62: 467-492
Clements, C.J.; Abdool-Karim, Q.; Chang, M.-L.; Nkowane, B.; Esparza, J. 2004: Breaking new ground--are changes in immunization services needed for the introduction of future HIV/AIDS vaccines and other new vaccines targeted at adolescents? Vaccine 22(21-22): 2822-2826
Simeonov, S.; Vasilev, V.; Iotov, M. 1973: Comparative testing of saponified vaccines against Aujeszky's disease Veterinarno-Meditsinski Nauki 10(2): 83-88
Stehr, K.; Enders-Ruckle, G.; Spiess, H. 1975: Measles vaccination with split vaccines and living vaccines Münchener Medizinische Wochenschrift 117(27): 1159-1164
Saraiva, V. 2003: Vaccines and foot-and-mouth disease eradication in South America Developments in Biologicals 114: 67-77
Libwea, J.N.; Kobela, M.; Ollgren, J.; Emah, I.; Tchio, R.; Nohynek, H. 2014: Predictors to parental knowledge about childhood immunisation/EPi vaccines in two health districts in Cameroon prior to the introduction of 13-valent Pneumococcal Conjugate Vaccines (PCV-13) Pan African Medical Journal 17: 187
Saraiva, V.; Darsie, G. 2004: The use of vaccines in South American foot-and-mouth disease eradication programmes Developments in biologicals 119: 33-40
Tate, J.E.; Arora, R.; Bhan, M.Kishan.; Yewale, V.; Parashar, U.D.; Kang, G. 2014: Rotavirus disease and vaccines in India: a tremendous public health opportunity Vaccine 32 Suppl. 1: Vii-Xii